Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005)

Mark Boyd; Preeyaporn Srasuebkul; Mana Khongphattanoyothin; Kiat Ruxrungtham; Elly Hassink; Christopher Duncombe; Sasiwimol Ubolyam; David Burger; Peter Reiss; Michael Stek; Joep Lange; David Cooper; Praphan Phanuphak

Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005)

Mark Boyd, Preeyaporn Srasuebkul, Mana Khongphattanoyothin, Kiat Ruxrungtham, Elly Hassink, Christopher Duncombe, Sasiwimol Ubolyam, David Burger, Peter Reiss, Michael Stek, Joep Lange, David Cooper, Praphan Phanuphak

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

Original language	English
Pages (from-to)	223-232
Number of pages	10
Journal	Antiviral Therapy
Volume	11
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Boyd, M., Srasuebkul, P., Khongphattanoyothin, M., Ruxrungtham, K., Hassink, E., Duncombe, C., Ubolyam, S., Burger, D., Reiss, P., Stek, M., Lange, J., Cooper, D., & Phanuphak, P. (2006). Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005). Antiviral Therapy, 11, 223-232.

@article{34327903ded94ed1b2f211765c4c91a7,

title = "Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005)",

author = "Mark Boyd and Preeyaporn Srasuebkul and Mana Khongphattanoyothin and Kiat Ruxrungtham and Elly Hassink and Christopher Duncombe and Sasiwimol Ubolyam and David Burger and Peter Reiss and Michael Stek and Joep Lange and David Cooper and Praphan Phanuphak",

year = "2006",

language = "English",

volume = "11",

pages = "223--232",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "Sage Publications",

}

Boyd, M, Srasuebkul, P, Khongphattanoyothin, M, Ruxrungtham, K, Hassink, E, Duncombe, C, Ubolyam, S, Burger, D, Reiss, P, Stek, M, Lange, J, Cooper, D & Phanuphak, P 2006, 'Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005)', Antiviral Therapy, vol. 11, pp. 223-232.

TY - JOUR

T1 - Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005)

AU - Boyd, Mark

AU - Srasuebkul, Preeyaporn

AU - Khongphattanoyothin, Mana

AU - Ruxrungtham, Kiat

AU - Hassink, Elly

AU - Duncombe, Christopher

AU - Ubolyam, Sasiwimol

AU - Burger, David

AU - Reiss, Peter

AU - Stek, Michael

AU - Lange, Joep

AU - Cooper, David

AU - Phanuphak, Praphan

PY - 2006

Y1 - 2006

M3 - Article

SN - 1359-6535

VL - 11

SP - 223

EP - 232

JO - Antiviral Therapy

JF - Antiviral Therapy

ER -